The Effect of Platelet-rich Plasma on Pain, Function, and Quality of Life of Patients with Knee Osteoarthritis

Overview

Journal Pain Res Treat

Date 2014 Jan 4

PMID 24386565

Citations 23

Authors

Seyed Ahmad Raeissadat

Seyed Mansoor Rayegani

Marzieh Babaee

Elham Ghorbani

Affiliations

Soon will be listed here.

Abstract

Background. New studies in the management of knee osteoarthritis have focused on modern therapeutic methods stimulating cartilage healing process. In the present study, we evaluated the effects of 2 courses of leucocyte-rich PRP (LR-PRP) injections on patients' QOL and functions and also the relationship between the PRP concentration and mentioned variables. Material and Methods. Sixty-five patients were evaluated. For each participant, WOMAC and the native (Farsi) edition of the SF-36 questionnaire were filled. Two courses of LR-PRP injections with 4-week interval were used. After 6 months, SF-36 and WOMAC questionnaires were filled again for each patient. Results. 60 patients were included in the final analysis. The mean platelet concentrations and white blood cell in PRP was 5-fold increase and 220 per microliter, respectively. The mean total WOMAC revealed significant change (P = 0.001). In SF-36, the mean changes of 2 major physical and mental domains were meaningful (P = 0.001). Discussion. In our study, 2 injections of PRP, with 4-week interval, improved the pain, stiffness, and functional capacity. Improvements in QOL (both PCS and MCS) were meaningful after injections. These changes were more significant in physical domains. PRP injection may be an alternative therapy in selective patients resistant to current nonsurgical treatments of knee osteoarthritis.

Citing Articles

Clinical research progress of umbilical cord blood mesenchymal stem cells in Knee articular cartilage repair: A review.

Liao Z Medicine (Baltimore). 2025; 104(6):e41402.

PMID: 39928895 PMC: 11813059. DOI: 10.1097/MD.0000000000041402.

Platelet-rich Plasma as Effectiveness in the Treatment of Osteoarthrosis of the Knee in a Tertiary Care Center.

Teja A, Kumar M, Shashank C, Saifuddin R, Tiwari R, Thakkar S J Pharm Bioallied Sci. 2024; 16(Suppl 1):S296-S298.

PMID: 38595432 PMC: 11000861. DOI: 10.4103/jpbs.jpbs_499_23.

Platelet-Rich Plasma in the Management of Temporomandibular Joint Pain in Young Adults With Temporomandibular Disorder.

Mathpati S, Jain G, Mishra V, Singh A, Mishra R, Yadav B Cureus. 2024; 16(3):e55609.

PMID: 38586782 PMC: 10995649. DOI: 10.7759/cureus.55609.

Clinical use of Plasma Protein from Platelet in Degenerative Joint Disease: A Prospective Study.

Christin I, Muthukannan H, Karuppanan S, Chhajed S, Suggu S, Moitra S J Orthop Case Rep. 2023; 12(11):105-109.

PMID: 37013232 PMC: 10066673. DOI: 10.13107/jocr.2022.v12.i11.3434.

Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities.

Ramasamy T, Yee Y, Khan I Front Cell Dev Biol. 2021; 9:625497.

PMID: 34336816 PMC: 8318388. DOI: 10.3389/fcell.2021.625497.

References

Smyth N, Murawski C, Fortier L, Cole B, Kennedy J . Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy. 2013; 29(8):1399-409. DOI: 10.1016/j.arthro.2013.03.004. View

Zhu Y, Yuan M, Meng H, Wang A, Guo Q, Wang Y . Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage. 2013; 21(11):1627-37. DOI: 10.1016/j.joca.2013.07.017. View

Marx R . Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2002; 10(4):225-8. DOI: 10.1097/00008505-200110000-00002. View

De La Mata J . Platelet rich plasma. A new treatment tool for the rheumatologist?. Reumatol Clin. 2012; 9(3):166-71. DOI: 10.1016/j.reuma.2012.05.011. View

Wehberg K, Answini G, Wood D, Todd J, Julian J, Ogburn N . Intramyocardial injection of autologous platelet-rich plasma combined with transmyocardial revascularization. Cell Transplant. 2009; 18(3):353-9. DOI: 10.3727/096368909788534988. View

Park Y, Han S, Song S, Kim T, Ha C . Platelet-rich plasma therapy for knee joint problems: review of the literature, current practice and legal perspectives in Korea. Knee Surg Relat Res. 2012; 24(2):70-8. PMC: 3374002. DOI: 10.5792/ksrr.2012.24.2.70. View

Mishra A, Woodall Jr J, Vieira A . Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2008; 28(1):113-25. DOI: 10.1016/j.csm.2008.08.007. View

Sampson S, Gerhardt M, Mandelbaum B . Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2009; 1(3-4):165-74. PMC: 2682411. DOI: 10.1007/s12178-008-9032-5. View

Emel E, Ergun S, Kotan D, Basar Gursoy E, Parman Y, Zengin A . Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model. J Neurosurg. 2010; 114(2):522-8. DOI: 10.3171/2010.9.JNS091928. View

10.

Gobbi A, Karnatzikos G, Mahajan V, Malchira S . Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012; 4(2):162-72. PMC: 3435904. DOI: 10.1177/1941738111431801. View

11.

McConnell S, Kolopack P, Davis A . The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001; 45(5):453-61. DOI: 10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w. View

12.

Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A . Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011; 27(11):1490-501. DOI: 10.1016/j.arthro.2011.05.011. View

13.

Kim S, Stitik T, Foye P, Greenwald B, Campagnolo D . Critical review of prolotherapy for osteoarthritis, low back pain, and other musculoskeletal conditions: a physiatric perspective. Am J Phys Med Rehabil. 2004; 83(5):379-89. DOI: 10.1097/01.phm.0000124443.31707.74. View

14.

Misso M, Pitt V, Jones K, Barnes H, Piterman L, Green S . Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust. 2008; 189(7):394-9. DOI: 10.5694/j.1326-5377.2008.tb02086.x. View

15.

Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B . Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2011; 89(12):961-9. DOI: 10.1097/PHM.0b013e3181fc7edf. View

16.

Kijowski R, Blankenbaker D, Stanton P, Fine J, De Smet A . Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint. AJR Am J Roentgenol. 2006; 187(3):794-9. DOI: 10.2214/AJR.05.1123. View

17.

Filardo G, Kon E, Di Martino A, Di Matteo B, Merli M, Cenacchi A . Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012; 13:229. PMC: 3532098. DOI: 10.1186/1471-2474-13-229. View

18.

Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A . Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2009; 18(4):472-9. DOI: 10.1007/s00167-009-0940-8. View

19.

Napolitano M, Matera S, Bossio M, Crescibene A, Costabile E, Almolla J . Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus. 2011; 10(1):72-7. PMC: 3258992. DOI: 10.2450/2011.0026-11. View

20.

Hall M, Band P, Meislin R, Jazrawi L, Cardone D . Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009; 17(10):602-8. DOI: 10.5435/00124635-200910000-00002. View